Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 4166  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page

    Article Cited by others

CORRESPONDENCE

Ebastine in chronic spontaneous urticaria in higher doses

Godse Kiran V

Year : 2011| Volume: 56| Issue : 5 | Page no: 597-598

   This article has been cited by
 
1 Efficacy and safety of ebastine dose escalation in chronic urticaria: A prospective study
Tian Qian, Shifei Li, Qiquan Chen, Daojun Zhang, Zhiqiang Song, Fei Hao
Dermatologic Therapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective
Alaa Alnefaie, Sarah Albogami
Saudi Pharmaceutical Journal. 2020; 28(11): 1333
[Pubmed]  [Google Scholar] [DOI]
3 EBASTINE. A REASONABLE CHOICE
I S Gushchin, I V Danilicheva
Russian Journal of Allergy. 2017; 14(4-5): 89
[Pubmed]  [Google Scholar] [DOI]
4 Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria
Mario Sánchez-Borges,Ignacio Ansotegui,Jorge Jimenez,Maria Rojo,Carlos Serrano,Anahí Yañez
World Allergy Organization Journal. 2014; 7(1): 33
[Pubmed]  [Google Scholar] [DOI]
5 Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: Is there evidence for updosing?
Sánchez-Borges, M., Caballero-Fonseca, F., Capriles-Hulett, A.
Journal of Investigational Allergology and Clinical Immunology. 2013; 23(3): 141-144
[Pubmed]  [Google Scholar]

 

Read this article